Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

EGFR PACC

Clinical trials for EGFR PACC explained in plain language.

Never miss a new study

Get alerted when new EGFR PACC trials appear

Sign up with your email to follow new studies for EGFR PACC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1
Sort by
  • New hope for rare lung cancer: targeted drug trial launches

    Disease control Recruiting now

    This study tests a new drug, firmonertinib, against two standard treatments for people with advanced non-small-cell lung cancer that has specific rare genetic changes (EGFR PACC mutations). About 480 participants who have not had prior treatment for advanced disease will be rando…

    Matched conditions: EGFR PACC

    Phase: PHASE3 • Sponsor: ArriVent BioPharma, Inc. • Aim: Disease control

    Last updated May 01, 2026 16:01 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space